Millipore promises pure biologics

By staff reporter

- Last updated on GMT

Related tags Biotechnology

Millipore has announced the first fruit of its collaboration with
testing specialist Gen-Probe, with the launch of a new contaminant
detection system for biopharmaceutical manufacturers.

This first joint product from their partnership to create faster, sensitive, more robust tests for detecting contaminants in pharmaceutical and biotech production processes is the latest addition to Millipore's processing portfolio. The speed of the so-called MilliPROBE test is emphasised as it allows manufacturers to take corrective action earlier in the production process, which both reduces risks later on and improves the quality of the final product. "For the first time, [scientists] have a viable alternative to culture-based tests that can take several days to generate results,"​ said Martin Madaus, CEO of Millipore. The system combines Millipore's sample preparation methods with Gen-Probe's nucleic acid technologies in one microbial screening tool. It uses real-time Transcription Mediated Amplification (TMA) technology to detect microbial contamination within hours rather than the days or weeks needed when using the traditional cell-culture tests. "We are excited about the progress we have made in our collaboration with Gen-Probe and we look forward to developing additional assays using the MilliProbe system over the next few years,"​ added Madaus. This first assay targets the bacterium Pseudomonas aeruginosa​, which can be found in purified water used during drug production. The two companies intend to add several new assays for different contaminants over the coming years. "We believe there is a bright future for this new generation of rapid, real-time TMA-based screening tools,"​ said Hank Nordhoff, CEO of Gen-Probe.

Related news

Show more

Related products

Efficient Freezing & Storage of Biopharmaceuticals

Efficient Freezing & Storage of Biopharmaceuticals

Content provided by Single Use Support | 06-Nov-2023 | White Paper

Various options exist for freezing biopharmaceutical bulk material, but selecting the most effective and efficient approach for each cold chain can be...

Understanding the hidden value of quality

Understanding the hidden value of quality

Content provided by Thermo Fisher Scientific – Production Chemicals and Services | 16-Jan-2023 | White Paper

The raw material supply is too vital to leave to chance, and quality-related supply chain activities are cornerstones to your success.

Follow us


View more